Meet Kalos Therapeutics: Phoenix-based biomedical company

Published: 12/04/2019
Updated: 05/17/2021

As a region, we’re on a relentless pursuit of innovation and technology, and companies here are committed to changing the game. It’s all about people, place and tech in Greater Phoenix. Learn more about Kalos Therapeutics’ story from their CEO and Co-Founder George Colberg. 

Tell us about your company: 

George Colberg: Kalos Therapeutics, Inc. is pioneering the first nontoxic therapy to treat primary tumors and metastasis. Kalos can be a lead, combination and safe long-term therapy for cancer. This approach will allow for reduced toxicity and safe long-term use, and eliminate or reverse resistance.  

Kalos has created a new concept, the “cancer tune-up for life.” The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014. This number is expected to rise to almost 19 million by 2024. In 2018, in the U.S., there will be about 1,735,350 new cancer cases and 609,640 deaths with no safe, long-term therapy. Kalos will replace the drug holiday with a safe, long-term maintenance therapy. Patients will enjoy improved quality of life and survival-tumor control. The Kalos solution will play an active role in all therapeutic protocols in cancer. 

What city in Arizona is your company located in? 

Colberg: Phoenix 

How did your company get started? 

Colberg: Searching for a nontoxic therapy for cancer that could be used for virulent cancers, metastatic disease and as a long-term maintenance. 

What makes your product unique and different? 

Colberg: We have a nontoxic cancer drug which will be useful as a lead therapy and in combination with existing drugs. We can also safely treat metastatic disease. 

Explain why you chose Greater Phoenix to build your company: 

Colberg: Great science and people, wonderful community, and an opportunity to help create a viable and sustainable ecosystem for therapeutics in the biomedical arena.  

What is the best thing about having your business in Greater Phoenix? 

Colberg: The quality of life! The proximity to major biomedical hubs and Greater Phoenix is a fast-growing, supportive investment community. 

In your opinion, why should someone build a career in Greater Phoenix? 

Colberg: There is an air of excitement in the tech and biomedical communities. There are tremendous new opportunities and it is a wonderful place to live. Phoenix will be a leader in STEM and health care. 

What are three words you would use to describe the business community in Greater Phoenix? 

Colberg: Welcoming, supportive, growing 

Are you currently hiring? If so, what types of positions do you need filled now? What about in the future? 

Colberg: In the future: Project manager, Clinical program lead and regulatory. 

Find out more about Kalos Therapeutics on Facebook. 

 

WANT TO SHARE YOUR BUSINESS’ STORY AND BE FEATURED ON THE REGIONAL?

Complete our survey!